Balchem (NASDAQ:BCPC) Shares Down 85.6% - Here's What Happened

Balchem Corporation (NASDAQ:BCPC - Get Free Report)'s stock price dropped 85.6% during trading on Monday . The company traded as low as $160.66 and last traded at $23.26. 36,180 shares were traded during trading, a decline of 74% from the average daily volume of 140,526 shares. The stock had previously closed at $161.53.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. Sidoti upgraded shares of Balchem to a "hold" rating in a report on Tuesday, February 25th. Finally, HC Wainwright set a $180.00 target price on Balchem and gave the stock a "buy" rating in a research note on Monday, April 28th.

Balchem Trading Up 0.3%

The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.40 and a current ratio of 2.44. The stock has a market capitalization of $5.21 billion, a P/E ratio of 38.31, a price-to-earnings-growth ratio of 3.45 and a beta of 0.91. The stock has a 50-day moving average price of $163.18 and a two-hundred day moving average price of $164.32.

Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($0.03). The company had revenue of $250.52 million during the quarter, compared to the consensus estimate of $245.70 million. Balchem had a net margin of 14.16% and a return on equity of 12.01%. The business's revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.03 EPS. On average, research analysts forecast that Balchem Corporation will post 4.64 EPS for the current fiscal year.

Institutional Investors Weigh In On Balchem

A number of large investors have recently modified their holdings of BCPC. Compound Planning Inc. raised its stake in Balchem by 4.1% in the first quarter. Compound Planning Inc. now owns 1,789 shares of the basic materials company's stock worth $297,000 after buying an additional 70 shares in the last quarter. Quadrant Capital Group LLC grew its holdings in shares of Balchem by 8.2% during the 4th quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock worth $161,000 after acquiring an additional 75 shares during the period. Covestor Ltd raised its position in shares of Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after acquiring an additional 76 shares in the last quarter. Arizona State Retirement System lifted its stake in shares of Balchem by 0.8% in the 4th quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock valued at $1,534,000 after purchasing an additional 77 shares during the period. Finally, Vident Advisory LLC lifted its stake in shares of Balchem by 6.0% in the 4th quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock valued at $232,000 after purchasing an additional 80 shares during the period. Institutional investors own 87.91% of the company's stock.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.